Multicentre study of cefiderocol for treatment of Gram-negative bacteria infections in critically ill patients.
Balandín B, Pintado V, Pérez-Pedrero MJ, Martínez-Sagasti F, Sancho-González M, Soriano-Cuesta C, Gesso CM, Chicot M, de Luna RR, Asensio-Martín MJ, Catalan M, Díaz-Díaz JJ, Carbonell N, Iranzo R, Royuela A, Ballesteros D.
Balandín B, et al. Among authors: perez pedrero mj.
Int J Antimicrob Agents. 2024 May;63(5):107121. doi: 10.1016/j.ijantimicag.2024.107121. Epub 2024 Feb 24.
Int J Antimicrob Agents. 2024.
PMID: 38408494
No abstract available.